| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 18,723 | 19,329 | 23,389 | | Cost of Revenue | 2,369 | 2,561 | 2,135 | | | Gross Profit | 16,354 | 16,768 | 21,254 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 431 | 440 | 406 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 15,923 | 16,329 | 20,849 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,191) | (13,339) |
-
| | Earnings Before Interest And Taxes | 15,923 | 16,329 | 20,849 | | Interest Expense | 400 | 891 | 611 | | Income Before Tax | 15,523 | 15,437 | 20,238 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 333 | 2,098 | 20,238 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 333 | 2,098 | 20,238 | | Preferred Stock And Other Adjustments | (3,239) | (4,736) | (3,722) | | | Net Income Applicable To Common Shares | ($2,907) | ($2,638) | $16,516 |
|
0.11% Nasdaq 
0.01%
Income Statement
